Welcome to AparnaBio
AparnaBio is a privately held biotechnology company formed to pursue our passion to develop biomedical nanoparticle technology and products for research and treatment of human disease. We are developing NanoElectroPlex™, a proprietary tissue selective nanoparticle platform technology based on biodegradable macromolecular carriers.
We have launched our InVivoPlex® – TUMOR reagent system for in vivo delivery of siRNA and gene expression plasmids for research use. We welcome the opportunity to engage with collaborators and partners in academia and industry to apply our technology to the in vivo delivery of novel experimental and therapeutic molecules.